Primary Central Nervous System Lymphomas and Related Disease Biology, Pathology, and Treatment

  • ISBN : 9784939028649
  • ページ数 : 237頁
  • 書籍発行日 : 2019年1月
  • 電子版発売日 : 2019年7月17日
  • 判 : A4判
  • 種別 : eBook版 → 詳細はこちら
販売価格 (ダウンロード販売)
¥14,300 (税込)
ポイント : 260 pt (2%)

便利機能

  • 対応
  • 一部対応
  • 未対応
便利機能アイコン説明
  • 全文・
    串刺検索
  • 目次・
    索引リンク
  • PCブラウザ閲覧
  • メモ・付箋
  • PubMed
    リンク
  • 動画再生
  • 音声再生
  • 今日の治療薬リンク
  • イヤーノートリンク
  • 南山堂医学
    大辞典
    リンク
  • 対応
  • 一部対応
  • 未対応

商品情報

This book presents a comprehensive description of a diagnostic and therapeutic aid for primary central nervous system lymphomas and related diseases. The 22 chapters detail the biology, pathology, and treatment of primary central nervous system lymphomas. Chapters 1-8 provide basic information on the biology of primary central nervous system lymphomas, and Chapters 9-18 are devoted to the basic pathology of primary central nervous system lymphomas and related diseases. The epidemiology, neuroimaging, and treatments of primary central nervous system lymphomas are discussed in Chapters 19-22. Pathologists, neurosurgeons, neurologists, radiologists, and other physicians will find this book of great benefit in diagnosing and combating dangerous tumors, primary central nervous system lymphomas, and related diseases.

■ 序文

Preface

Although recent advances in neuroscience have provided physicians with important information regarding primary central nervous system lymphomas and related diseases, the prognosis of patients with primary central nervous system lymphomas remains unsatisfactory. Furthermore, it is often difficult to clinicopathologically differentiate between primary central nervous system lymphomas and other brain lesions, such as malignant gliomas, infarctions, metastatic brain tumors, demyelinating diseases, and inflammatory diseases. A variety of primary central nervous system lymphomas and related diseases have also been highlighted in recent years.

This book has been designated principally as a diagnostic and therapeutic aid for physicians with regard to primary central nervous system lymphomas and related diseases. The 22 chapters detail the biology, pathology, and treatment of primary central nervous system lymphomas. Chapters 1-8 provide basic information on the biology of primary central nervous system lymphomas, and Chapters 9-18 are devoted to the basic pathology of primary central nervous system lymphomas and related diseases. The epidemiology, neuroimaging, and treatments of primary central nervous system lymphomas are discussed in Chapters 19-22.

I sincerely hope that this book will be of practical use to pathologists, neurosurgeons, neurologists, radiologists, and other physicians in diagnosing and combating dangerous tumors, primary central nervous system lymphomas, and related diseases.


Yasuo Sugita, MD

Department of Pathology, Kurume University School of Medicine

■ 目次

PART Ⅰ.BIOLOGY

Chapter 1.Angiogenesis of primary central nervous system lymphomas: The role of endoglin (CD105)

Chapter 2.The perivascular microenvironment in primary central nervous system lymphomas: The role of chemokines and the endothelin B receptor

Chapter 3.The signaling of ghrelin and its functional receptor, the growth hormone secretagogue receptor, promotes tumor growth in brain tumors

Chapter 4.Programmed death 1/Programmed cell death ligand 1 in malignant lymphoma

Chapter 5.The perivascular microenvironment in primary central nervous system lymphomas: The role of programmed cell death 1 and programmed cell death ligand 1

Chapter 6.SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts

Chapter 7.Expression of cyclooxygenase-2 and vascular endothelial growth factor in primary central nervous system lymphomas

Chapter 8.Role of tumor-associated macrophages in malignant lymphoma

PART Ⅱ.PATHOLOGY

Chapter 9.Intraoperative rapid diagnosis of primary central nervous system lymphomas: Benefits and pitfalls

Chapter 10.Pathology of primary B-cell lymphomas of the central nervous system

Chapter 11.Pathology of primary T-and NK-cell lymphomas of the central nervous system

Chapter 12.Epstein-Barr virus-positive diffuse large B-cell lymphoma of the central nervous system, not otherwise specified

Chapter 13.Iatrogenic immunodeficiency-associated lymphoproliferative disorders

Chapter 14.Epstein-Barr virus-positive lymphoproliferative disorder associated with old organized chronic subdural hematoma

Chapter 15.AIDS-related primary central nervous system lymphomas

Chapter 16.Lymphomatoid granulomatosis of the central nervous system

Chapter 17.Central nervous system lymphomas with cognitive symptoms: The pitfall of diagnosis in the early stages of dementia

Chapter 18.Tumefactive demyelinating disease mimicking primary central nervous system lymphomas

PART Ⅲ.TREATMENT

Chapter 19.The epidemiology of primary central nervous System lymphomas

Chapter 20.Diffuse large B-cell type lymphoma of the central nervous system: Characteristic findings on MRI

Chapter 21.Therapeutic options for Primary central nervous system lymphomas

Chapter 22.Treatments of primary central nervous system lymphomas

■ 特記事項

※今日リンク、YNリンク、南山リンクについて、AndroidOSは今後一部製品から順次対応予定です。製品毎の対応/非対応は上の「便利機能」のアイコンをご確認下さいませ。


※ご入金確認後、メールにてご案内するダウンロード方法によりダウンロードしていただくとご使用いただけます。


※コンテンツの使用にあたり、M2Plus Launcher(iOS/iPhoneOS/AndroidOS)が必要です。


※書籍の体裁そのままで表示しますため、ディスプレイサイズが7インチ以上の端末でのご使用を推奨します。


対応機種

  • ios icon

    iOS 10.0 以降

    外部メモリ:46.7MB以上(インストール時:96.8MB以上)

  • android icon

    AndroidOS 5.0 以降

    外部メモリ:81.6MB以上(インストール時:166.6MB以上)

  • コンテンツのインストールにあたり、無線LANへの接続環境が必要です(3G回線によるインストールも可能ですが、データ量の多い通信のため、通信料が高額となりますので、無線LANを推奨しております)。
  • コンテンツの使用にあたり、M2Plus Launcherが必要です。 導入方法の詳細はこちら
  • Appleロゴは、Apple Inc.の商標です。
  • Androidロゴは Google LLC の商標です。

まだ投稿されていません